Drug intelligence / Profile preview

CM-BA-9

Development stage
Phase 1
Lead developer
Liangyou Gu
Modality
Cell Therapies
Administration
Intratumoral
01

Overview

CM-BA-9 is an investigational chimeric antigen receptor macrophage (CAR-M) cell therapy targeting carbonic anhydrase IX (CA9). Developed by Liangyou Gu, it is designed for the treatment of unresectable or metastatic clear cell renal cell carcinoma (ccRCC). CA9 is a cell-surface protein highly overexpressed in ccRCC. CM-BA-9 consists of autologous or donor-derived macrophages genetically engineered to express a CAR targeting CA9, which enables them to specifically recognize and phagocytose CA9-expressing tumor cells, secrete pro-inflammatory cytokines, and remodel the immunosuppressive tumor microenvironment. It is administered via intratumoral injection.

Other names
CA9-targeted CAR-MCA-9-targeted CAR-MCA 9-targeted CAR-MCA9-targeted chimeric antigen receptor macrophage therapyCA-9-targeted chimeric antigen receptor macrophage therapyCA 9-targeted chimeric antigen receptor macrophage therapy

Beyond the preview

Go deeper on CM-BA-9.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CM-BA-9.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call